Director, US Oncology Marketing, INT Treatment Site Strategy & Execution Lead

Director, US Oncology Marketing, INT Treatment Site Strategy & Execution Lead

The U.S. Oncology business within our company is a growing and dynamic part of our company. We have an exciting opportunity to join our dynamic marketing team focusing on intismeran autogene, a cutting-edge individualized neoantigen therapy (INT), which represents a transformative approach to cancer treatment, as part of our alliance partnership. We are seeking a Director, US Oncology Marketing, INT Treatment Site Strategy & Execution Lead. This role will be pivotal in the development and execution of innovative strategic commercial plans to support the seamless end-to-end patient journey for intismeran autogene. This process begins with the acquisition of patient tumor and blood samples, genetic sequencing of the samples, customized manufacturing of the individualized therapy and subsequent delivery back to the health care provider for administration to the patient in combination with our immuno-oncology product. This role will also drive the strategy to develop the treatment site network and site readiness for the launch of intismeran autogene. This position will report to the Executive Director, U.S. Oncology Marketing, Intismeran Autogene / Alliance Lead and work cross-functionally with multiple teams across the organization to support the launch of this innovative therapy.

Key Responsibilities

• Develop and implement orchestration systems and processes to support the seamless end-to-end patient journey at treatment sites and ensure alignment with several cross functional teams that are involved in intismeran autogene treatment process, including but not limited to global orchestration lead, manufacturing, supply chain, IT, legal / compliance, market access, marketing, precision medicine, and field commercial.
• Lead and develop the treatment network strategy to identify intismeran autogene treatment sites, site readiness strategy to integrate INT operations into treatment sites, and address potential operational bottlenecks at sites, ensuring a smooth commercial ordering experience.
• Provide guidance and input for the development of the customer-facing INT orchestration software based on US market strategic needs and customer insights.
• Collaborate closely with the Precision Medicine team to facilitate a smooth patient tumor and blood sample collection process, securing a seamless path to therapy manufacturing.
• Enable the development and execution of the customer-facing field role strategy, focused on designing an effective field customer engagement model that aligns with unique business needs for intismeran autogene, including treatment site readiness and INT operational needs.
• Identify strengths and risks to customer experience in the end-to-end patient journey. Develop and implement risk-mitigation strategies and enhancement features to support optimal customer experience with INT.
• Research and implement industry best practices, identifying potential risks and gaps specific for INT, based on insights from similar individualized complex therapies (e.g. cell therapy, gene therapy, radioligand therapy).

Required :

Preferred :

Location :

Upper Gwynedd, PA, Rahway, NJ OR Remotely located

Required Skills :

Business Management, Communication, Customer Engagement, Data Analysis, Decision Making, Digital Marketing Campaigns, Gene Therapy, Healthcare Personnel (HCP) Marketing, Innovation, Leadership, Oncology Marketing, Risk Mitigation Strategies, Strategic Product Planning, Strategic Thinking, Team Management

US and Puerto Rico Residents Only :

Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities.